ResMed sells its MatrixCare software business to Frazier for $490m
THE SO WHAT
ResMed shedding MatrixCare for $490M is another example of hardware-centric players refocusing on core devices while PE consolidates vertical healthcare software. If you sell into post-acute or senior care, expect MatrixCare under Frazier to push harder on upsell, integration, and roll-up synergies.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureIsraeli startup Velocity, which helps place targeted ads on consumer and B2B AI platforms, raised a $27M seed led by NFX and Red Dot, and serves 20 clients
$27M into an ad network for AI apps is a clear bet that assistants and copilots are the next performance marketing surface. If you run a consumer or B2B AI product, you now have to decide whether you’re an ad channel, a commerce channel, or a neutral tool — and design UX and data policies accordingly.
Startups & VentureFamiliar Names Top Active US Investor Ranks In Q2
The same big funds topping Q2 activity and spend charts means capital is still concentrated in a few decision-making centers. Founders should calibrate that partner fit and narrative for these firms still heavily shape round dynamics — but also that competing for their attention is more zero-sum than the headline suggests.
Startups & VentureSambaNova raises fresh funding at an $11bn valuation as the Nvidia-alternative trade heats up
An $11B valuation and a 5x step-up in months says large buyers want credible second sources for AI compute, not just discounts from incumbents. If you’re planning multi-year model bets, start modeling a dual-vendor accelerator strategy—supply concentration is now a board-level risk, not just a procurement headache.
Startups & VentureBoredom is a business risk startups can’t afford to take
If your product, culture, or narrative is boring, you will lose talent, customers, and capital to teams that feel more alive—especially in a market where AI compresses functional differentiation. Founders should treat “emotional engagement” as a design constraint, not a marketing afterthought.